bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.01.21.477218

Predictive coding in ASD: inflexible weighting of prediction errors when switching from stable to volatile environments

Abstract

The nature of predictive-processing differences between individuals with autism spectrum disorder (ASD) and typically developing (TD) individuals is widely debated. Some studies suggest impairments in predictive processing in ASD, while others report intact processes, albeit with atypical learning dynamics. Here, we assessed duration reproduction tasks in high- and low-volatility settings to examine the updating dynamics of prior beliefs and sensory estimates. Employing a two-state Bayesian model, we differentiated how individuals with ASD and TD controls update their priors and perceptual estimates, and how these updates affect long-term prediction and behavior. Our findings indicate that individuals with ASD use prior knowledge and sensory input similarly to TD controls in perceptual estimates. However, they place a greater weight on sensory inputs specifically for iteratively updating their priors. This distinct approach to prior updating led to slower adaptation across trials; individuals with ASD relied less on their priors in perceptual estimates during the first half of sessions but achieved comparable integration weights as TD controls by the end of the session. By differentiating these aspects, our study highlights the importance of considering inter-trial updating dynamics to reconcile diverse findings of predictive processing in ASD. In consequence to the current findings, we suggest the distinct iterative updating account of predictive processing in ASD. Significance StatementResearch on predictive processing in Autism Spectrum Disorder (ASD) remains controversial. The current study employed a two-state Bayesian model in varied volatility settings to explore inter-trial updating dynamics in ASD compared to typically developing (TD) peers. We found that individuals with ASD, while utilizing prior knowledge similarly to TD controls, place a disproportionate emphasis on sensory inputs when updating their priors. This unique pattern of slower adaptation during iterative updating leads to significant behavioral differences in the first half of trials between the two groups, but comparable levels by the end of the session. These findings not only highlight the importance of considering different timescales and dynamic updating processes in ASD, but also suggest that the predictive processing framework in ASD involves unique prior updating mechanisms that is likely associated with increased sensory reliance.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Shi, Z., Theisinger, L., Allenmark, F., Pistorius, R., Mueller, H. J., Falter-Wagner, C.. 2022-01-25. Predictive coding in ASD: inflexible weighting of prediction errors when switching from stable to volatile environments. https://doi.org/10.1101/2022.01.21.477218

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗